Intrinsically active variants of all human p38 isoforms

FEBS Journal

Volumn 274, Issue 4, 2007, Pages 963-975

  Avitzour, Michal ^a   Diskin, Ron ^a   Raboy, Bilha ^a   Askari, Nadav ^a   Engelberg, David ^a   Livnah, Oded ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Active mutants; Autophosphorylation; Mitogen activated protein kinase; p38; Signal transduction

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 11; MITOGEN ACTIVATED PROTEIN KINASE 12; MITOGEN ACTIVATED PROTEIN KINASE 13; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MUTANT PROTEIN;

ARTICLE; AUTOPHOSPHORYLATION; CELL STRAIN HEK293; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; WILD TYPE;

AMINO ACID SEQUENCE; ENZYME INHIBITORS; HUMANS; IMIDAZOLES; KINETICS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN ISOFORMS; PYRIDINES; SUBSTRATE SPECIFICITY;

EUKARYOTA; MAMMALIA;

EID: 33846839324     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2007.05644.x     Document Type: Article

References (35)

1. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ & Davis RJ (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270, 7420-7426.
2. Kyriakis JM & Avruch J (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81, 807-869.
3. Zarubin T & Han J (2005) Activation and signaling of the p38 MAP kinase pathway. Cell Res 15, 11-18.
4. Jiang Y, Gram H, Zhao M, New L, Gu J, Feng L, Di Padova F, Ulevitch RJ & Han J (1997) Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J Biol Chem 272, 30122-30128.
5. Wang XS, Diener K, Manthey CL, Wang S, Rosenzweig B, Bray J, Delaney J, Cole CN, Chan-Hui PY, Mantlo N et al. (1997) Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J Biol Chem 272, 23668-23674.
6. Jiang Y, Chen C, Li Z, Guo W, Gegner JA, Lin S & Han J (1996) Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J Biol Chem 271, 17920-17926.
7. Stein B, Yang MX, Young DB, Janknecht R, Hunter T, Murray BW & Barbosa MS (1997) p38-2, a novel mitogen-activated protein kinase with distinct properties. J Biol Chem 272, 19509-19517.
8. Lechner C, Zahalka MA, Giot JF, Moller NP & Ullrich A (1996) ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sci USA 93, 4355-4359.
9. Enslen H, Brancho DM & Davis RJ (2000) Molecular determinants that mediate selective activation of p38 MAP kinase isoforms. EMBO J 19, 1301-1311.
10. Keesler GA, Bray J, Hunt J, Johnson DA, Gleason T, Yao Z, Wang SW, Parker C, Yamane H, Cole C et al. (1998) Purification and activation of recombinant p38 isoforms alpha, beta, gamma, and delta. Protein Expr Purif 14, 221-228.
11. Enslen H, Raingeaud J & Davis RJ (1998) Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem 273, 1741-1748.
12. Tanoue T, Yamamoto T, Maeda R & Nishida E (2001) A Novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs. J Biol Chem 276, 26629-26639.
13. Salvador JM, Mittelstadt PR, Guszczynski T, Copeland TD, Yamaguchi H, Appella E, Fornace AJ Jr & Ashwell JD (2005) Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases. Nat Immunol 6, 390-395.
14. Ge B, Gram H, Di Padova F, Huang B, New L, Ulevitch RJ, Luo Y & Han J (2002) MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha. Science 295, 1291-1294.
15. Diskin R, Askari N, Capone R, Engelberg D & Livnah O (2004) Active mutants of the human p38alpha mitogen-activated protein kinase. J Biol Chem 279, 47040-47049.
16. Shi Y & Gaestel M (2002) In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance. Biol Chem 383, 1519-1536.
17. Hu MC, Wang YP, Mikhail A, Qiu WR & Tan TH (1999) Murine p38-delta mitogen-activated protein kinase, a developmentally regulated protein kinase that is activated by stress and proinflammatory cytokines. J Biol Chem 274, 7095-7102.
18. Mudgett JS, Ding J, Guh-Siesel L, Chartrain NA, Yang L, Gopal S & Shen MM (2000) Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci USA 97, 10454-10459.
19. Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, Valladares A, Perez L, Klein R & Nebreda AR (2000) Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 6, 109-116.
20. Sabio G, Arthur JS, Kuma Y, Peggie M, Carr J, Murray-Tait V, Centeno F, Goedert M, Morrice NA & Cuenda A (2005) p38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J 24, 1134-1145.
21. Beardmore VA, Hinton HJ, Eftychi C, Apostolaki M, Armaka M, Darragh J, McIlrath J, Carr JM, Armit LJ, Clacher C et al. (2005) Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol Cell Biol 25, 10454-10464.
22. Bell M, Capone R, Pashtan I, Levitzki A & Engelberg D (2001) Isolation of hyperactive mutants of the MAPK p38 / Hog1 that are independent of MAPK kinase activation. J Biol Chem 276, 25351-25358.
23. Yaakov G, Bell M, Hohmann S & Engelberg D (2003) Combination of two activating mutations in one HOG1 gene forms hyperactive enzymes that induce growth arrest. Mol Cell Biol 23, 4826-4840.
24. Diskin R, Lebendiker M, Engelberg D & Livnah O (2007) Structures of p38alpha active mutants reveal conformational changes in L16 loop that induce autophosphorylation and activation. J Mol Biol 365, 66-76.
25. Wilson KP, Fitzgibbon MJ, Caron PR, Griffith JP, Chen W, McCaffrey PG, Chambers SP & Su MS (1996) Crystal structure of p38 mitogen-activated protein kinase. J Biol Chem 271, 27696-27700.
26. Canagarajah BJ, Khokhlatchev A, Cobb MH & Goldsmith EJ (1997) Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell 90, 859-869.
27. Bellon S, Fitzgibbon MJ, Fox T, Hsiao HM & Wilson KP (1999) The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation. Structure 7, 1057-1065.
28. Askari N, Diskin R, Avitzour M, Capone R, Livnah O & Engelberg D (2007) Hyperactive variants of P38alpha induce, whereas hyperactive variants of P38gamma suppress AP-1-mediated transcription. J Biol Chem 282, 91-99.
29. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC & Young PR (1997) Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 235, 533-538.
30. Gum RJ, McLaughlin MM, Kumar S, Wang Z, Bower MJ, Lee JC, Adams JL, Livi GP, Goldsmith EJ & Young PR (1998) Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J Biol Chem 273, 15605-15610.
31. Davies SP, Reddy H, Caivano M & Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351, 95-105.
32. Schwede T, Kopp J, Guex N & Peitsch MC (2003) SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 31, 3381-3385.
33. DeLano WL (2002) The PyMol Molecular Graphics System. DeLano Scientific, San Carlos.
34. Wang Z, Harkins PC, Ulevitch RJ, Han J, Cobb MH & Goldsmith EJ (1997) The structure of mitogen-activated protein kinase p38 at 2.1-A resolution. Proc Natl Acad Sci USA 94, 2327-2332.
35. Fox T, Fitzgibbon MJ, Fleming MA, Hsiao HM, Brummel CL & Su MS (1999) Kinetic mechanism and ATP-binding site reactivity of p38gamma MAP kinase. FEBS Lett 461, 323-328.